Can a cheap supplement cut deaths from alcoholic hepatitis?
NCT ID NCT05294744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding N-acetylcysteine (NAC) to standard steroid treatment helps people with severe alcoholic hepatitis live longer and have fewer complications. About 390 adults aged 18-75 with a high Maddrey score will be enrolled. The main goal is to see if the combination reduces deaths within 6 months compared to steroids alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLIC HEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ana Belén Fernández Laso
RECRUITINGVitoria-Gasteiz, Álava, 01009, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cow's first milk could be a lifeline for severe Alcohol-Related hepatitis
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Can a text-and-therapy program keep liver transplant patients sober?
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- Liver failure treatment MARS: does it help avoid transplants?
- Liver bacteria may hold key to new alcoholic hepatitis treatments